Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk for Cardiovascular Event”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Not applicableStudy completedNCT00347217
What this trial is testing

Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

Who this might be right for
Hypercholesteremia
AstraZeneca 3,840
Post-approval studies (Phase 4)UnknownNCT01013532
What this trial is testing

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Who this might be right for
Brain IschemiaIntracranial Hemorrhages
Asan Medical Center 1,600
Not applicableStudy completedNCT00481234
What this trial is testing

Heart Rate Variability for Prediction of Perioperative Events

Who this might be right for
AnesthesiaCoronary Heart Disease
University Hospital Schleswig-Holstein 2,002
Testing effectiveness (Phase 2)Looking for participantsNCT07654426
What this trial is testing

The CARDIOPROTECT Trial

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)CardiotoxicityLymphoma
Beth Israel Deaconess Medical Center 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06292013
What this trial is testing

Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Elevated Lp(a)
Eli Lilly and Company 17,300
Testing effectiveness (Phase 2)Study completedNCT01652703
What this trial is testing

Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects

Who this might be right for
Hypercholesterolemia and High Risk for Cardiovascular Events
Amgen 310
Not applicableStudy completedNCT00408057
What this trial is testing

Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE )

Who this might be right for
Cardiovascular Diseases
Canadian Heart Research Centre 2,500
Not applicableNot Yet RecruitingNCT07692503
What this trial is testing

How Institutional Guidelines for Urgent Inpatient Surgeries Affect Intensity of Perioperative Cardiovascular Testing

Who this might be right for
Major Adverse Cardiovascular EventsCardiovascular Testing and Consultation Intensity
Johns Hopkins University 3,000
Large-scale testing (Phase 3)Study completedNCT01516541
What this trial is testing

Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Who this might be right for
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Hoffmann-La Roche 2,220
Large-scale testing (Phase 3)UnknownNCT04205578
What this trial is testing

NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events

Who this might be right for
Moyamoya DiseaseIschemic Cerebral InfarctionIschemic Stroke+2 more
yuanli Zhao 450
Not applicableStudy completedNCT00586950
What this trial is testing

123I-BMIPP SPECT Analysis for Decreasing Cardiac Events in Hemodialysis Patients

Who this might be right for
Coronary DiseaseFatty Acids, UnsaturatedRadioisotopes+2 more
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 1,000
Post-approval studies (Phase 4)Study completedNCT00153101
What this trial is testing

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Who this might be right for
Cardiovascular Diseases
Boehringer Ingelheim 31,546
Testing effectiveness (Phase 2)Study completedNCT05563246
What this trial is testing

LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Who this might be right for
Lipoprotein Disorder
Eli Lilly and Company 233
Not applicableStudy completedNCT01972360
What this trial is testing

Non-isotope Based Imaging Modalities vs Technetium-99m Single-Photon Emission Computed Tomography(99mTcSPECT)

Who this might be right for
Myocardial Ischemia
Montreal Heart Institute 467
Post-approval studies (Phase 4)Active Not RecruitingNCT03947229
What this trial is testing

Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Who this might be right for
Coronary Artery DiseaseDES
Yonsei University 3,200
Large-scale testing (Phase 3)Study completedNCT01730534
What this trial is testing

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentHigh Risk for Cardiovascular Event
AstraZeneca 17,190
Post-approval studies (Phase 4)Study completedNCT04418479
What this trial is testing

SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3

Who this might be right for
Coronary Artery Disease
Joo-Yong Hahn 5,506
Not applicableUnknownNCT05732714
What this trial is testing

Long Term Cardiovascular Disease Event Risk for Patients Undergoing Major Non-Cardiac Surgery

Who this might be right for
Cardiovascular DiseasesRisk Reduction Behavior
University Health Network, Toronto 50
Large-scale testing (Phase 3)Study completedNCT00335452
What this trial is testing

Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS

Who this might be right for
Acute Coronary DiseaseAngina Unstable
Sanofi 25,086
Large-scale testing (Phase 3)Study completedNCT01492361
What this trial is testing

AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin

Who this might be right for
Cardiovascular Diseases
Amarin Pharma Inc. 8,179
Next Page